Strategies for prevention of ultrasound-guided prostate biopsy infections

Diane D. Lu, Jay D. Raman

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Prostate cancer is the most common cancer in male patients and the second leading cause of cancer-related mortality in males. To confirm the diagnosis of prostate cancer, an ultrasound-guided needle biopsy is necessary to obtain prostate tissue sufficient for histologic analysis by pathologists. Ultrasound-guided prostate needle biopsy can be accomplished via a transperineal or transrectal approach. The latter biopsy technique involves placing an ultrasound probe into the rectum, visualizing the prostate located just anterior to it, and then obtaining 12-14 biopsies. Each biopsy core requires piercing of the rectal mucosa which can inherently contribute to infection. The increasing infectious risk of prostate needle biopsy requires refinement and re-evaluation of the process in which the technique is performed. Such processes include (but are not limited to) prebiopsy risk stratification, antibiotic prophylaxis, use of rectal preparations, and equipment processing. In the subsequent review, we highlight the current available information on different strategies to reduce the risk of infection following prostate needle biopsy.

Original languageEnglish (US)
Pages (from-to)161-169
Number of pages9
JournalInfection and Drug Resistance
Volume9
DOIs
StatePublished - Jul 8 2016

Fingerprint

Needle Biopsy
Prostate
Biopsy
Infection
Prostatic Neoplasms
Antibiotic Prophylaxis
Rectum
Neoplasms
Mucous Membrane
Equipment and Supplies
Mortality

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)

Cite this

@article{e3d3f2a652d2440eab55fb425ed428a3,
title = "Strategies for prevention of ultrasound-guided prostate biopsy infections",
abstract = "Prostate cancer is the most common cancer in male patients and the second leading cause of cancer-related mortality in males. To confirm the diagnosis of prostate cancer, an ultrasound-guided needle biopsy is necessary to obtain prostate tissue sufficient for histologic analysis by pathologists. Ultrasound-guided prostate needle biopsy can be accomplished via a transperineal or transrectal approach. The latter biopsy technique involves placing an ultrasound probe into the rectum, visualizing the prostate located just anterior to it, and then obtaining 12-14 biopsies. Each biopsy core requires piercing of the rectal mucosa which can inherently contribute to infection. The increasing infectious risk of prostate needle biopsy requires refinement and re-evaluation of the process in which the technique is performed. Such processes include (but are not limited to) prebiopsy risk stratification, antibiotic prophylaxis, use of rectal preparations, and equipment processing. In the subsequent review, we highlight the current available information on different strategies to reduce the risk of infection following prostate needle biopsy.",
author = "Lu, {Diane D.} and Raman, {Jay D.}",
year = "2016",
month = "7",
day = "8",
doi = "10.2147/IDR.S96163",
language = "English (US)",
volume = "9",
pages = "161--169",
journal = "Infection and Drug Resistance",
issn = "1178-6973",
publisher = "Dove Medical Press Ltd.",

}

Strategies for prevention of ultrasound-guided prostate biopsy infections. / Lu, Diane D.; Raman, Jay D.

In: Infection and Drug Resistance, Vol. 9, 08.07.2016, p. 161-169.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Strategies for prevention of ultrasound-guided prostate biopsy infections

AU - Lu, Diane D.

AU - Raman, Jay D.

PY - 2016/7/8

Y1 - 2016/7/8

N2 - Prostate cancer is the most common cancer in male patients and the second leading cause of cancer-related mortality in males. To confirm the diagnosis of prostate cancer, an ultrasound-guided needle biopsy is necessary to obtain prostate tissue sufficient for histologic analysis by pathologists. Ultrasound-guided prostate needle biopsy can be accomplished via a transperineal or transrectal approach. The latter biopsy technique involves placing an ultrasound probe into the rectum, visualizing the prostate located just anterior to it, and then obtaining 12-14 biopsies. Each biopsy core requires piercing of the rectal mucosa which can inherently contribute to infection. The increasing infectious risk of prostate needle biopsy requires refinement and re-evaluation of the process in which the technique is performed. Such processes include (but are not limited to) prebiopsy risk stratification, antibiotic prophylaxis, use of rectal preparations, and equipment processing. In the subsequent review, we highlight the current available information on different strategies to reduce the risk of infection following prostate needle biopsy.

AB - Prostate cancer is the most common cancer in male patients and the second leading cause of cancer-related mortality in males. To confirm the diagnosis of prostate cancer, an ultrasound-guided needle biopsy is necessary to obtain prostate tissue sufficient for histologic analysis by pathologists. Ultrasound-guided prostate needle biopsy can be accomplished via a transperineal or transrectal approach. The latter biopsy technique involves placing an ultrasound probe into the rectum, visualizing the prostate located just anterior to it, and then obtaining 12-14 biopsies. Each biopsy core requires piercing of the rectal mucosa which can inherently contribute to infection. The increasing infectious risk of prostate needle biopsy requires refinement and re-evaluation of the process in which the technique is performed. Such processes include (but are not limited to) prebiopsy risk stratification, antibiotic prophylaxis, use of rectal preparations, and equipment processing. In the subsequent review, we highlight the current available information on different strategies to reduce the risk of infection following prostate needle biopsy.

UR - http://www.scopus.com/inward/record.url?scp=84978864175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978864175&partnerID=8YFLogxK

U2 - 10.2147/IDR.S96163

DO - 10.2147/IDR.S96163

M3 - Review article

C2 - 27468242

AN - SCOPUS:84978864175

VL - 9

SP - 161

EP - 169

JO - Infection and Drug Resistance

JF - Infection and Drug Resistance

SN - 1178-6973

ER -